670 related articles for article (PubMed ID: 17631434)
1. Skeletal myoblasts as a therapeutic agent.
Menasché P
Prog Cardiovasc Dis; 2007; 50(1):7-17. PubMed ID: 17631434
[TBL] [Abstract][Full Text] [Related]
2. Cell transplantation--a potential therapy for cardiac repair in the future?
Gulbins H; Meiser BM; Reichenspurner H; Reichart B
Heart Surg Forum; 2002; 5(4):E28-34. PubMed ID: 12538127
[TBL] [Abstract][Full Text] [Related]
3. Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives.
Menasché P
Thromb Haemost; 2005 Oct; 94(4):697-701. PubMed ID: 16270619
[TBL] [Abstract][Full Text] [Related]
4. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
Menasché P; Alfieri O; Janssens S; McKenna W; Reichenspurner H; Trinquart L; Vilquin JT; Marolleau JP; Seymour B; Larghero J; Lake S; Chatellier G; Solomon S; Desnos M; Hagège AA
Circulation; 2008 Mar; 117(9):1189-200. PubMed ID: 18285565
[TBL] [Abstract][Full Text] [Related]
5. Cell-based therapy for heart failure: skeletal myoblasts.
Seidel M; Borczyńska A; Rozwadowska N; Kurpisz M
Cell Transplant; 2009; 18(7):695-707. PubMed ID: 19500482
[TBL] [Abstract][Full Text] [Related]
6. Current status and future prospects for cell transplantation to prevent congestive heart failure.
Menasché P
Semin Thorac Cardiovasc Surg; 2008; 20(2):131-7. PubMed ID: 18707646
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
Dib N; Michler RE; Pagani FD; Wright S; Kereiakes DJ; Lengerich R; Binkley P; Buchele D; Anand I; Swingen C; Di Carli MF; Thomas JD; Jaber WA; Opie SR; Campbell A; McCarthy P; Yeager M; Dilsizian V; Griffith BP; Korn R; Kreuger SK; Ghazoul M; MacLellan WR; Fonarow G; Eisen HJ; Dinsmore J; Diethrich E
Circulation; 2005 Sep; 112(12):1748-55. PubMed ID: 16172284
[TBL] [Abstract][Full Text] [Related]
8. Skeletal myoblasts and cardiac repair.
Menasché P
J Mol Cell Cardiol; 2008 Oct; 45(4):545-53. PubMed ID: 18187148
[TBL] [Abstract][Full Text] [Related]
9. Myocardial repair with autologous skeletal myoblasts: a review of the clinical studies and problems.
Smits PC
Minerva Cardioangiol; 2004 Dec; 52(6):525-35. PubMed ID: 15729213
[TBL] [Abstract][Full Text] [Related]
10. Endogenous cardiac stem cells.
Barile L; Messina E; Giacomello A; Marbán E
Prog Cardiovasc Dis; 2007; 50(1):31-48. PubMed ID: 17631436
[TBL] [Abstract][Full Text] [Related]
11. [Myoblast transplantation for heart failure: where are we heading?].
Menasché P; Hagège AA; Desnos M
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):649-54. PubMed ID: 16007819
[TBL] [Abstract][Full Text] [Related]
12. Skeletal myoblast transplantation for cardiac repair.
Menasché P
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):21-8. PubMed ID: 15038410
[TBL] [Abstract][Full Text] [Related]
13. Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy.
Eisen HJ
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):520-1. PubMed ID: 18648335
[TBL] [Abstract][Full Text] [Related]
14. [Stem cells after myocardial infarction].
Schächinger V; Dimmeler S; Zeiher AM
Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiological properties of stem cells].
Ravens U
Herz; 2006 Apr; 31(2):123-6. PubMed ID: 16738835
[TBL] [Abstract][Full Text] [Related]
16. Stem cells and their potential in cell-based cardiac therapies.
Christoforou N; Gearhart JD
Prog Cardiovasc Dis; 2007; 49(6):396-413. PubMed ID: 17498520
[TBL] [Abstract][Full Text] [Related]
17. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure.
McConnell PI; del Rio CL; Jacoby DB; Pavlicova M; Kwiatkowski P; Zawadzka A; Dinsmore JH; Astra L; Wisel S; Michler RE
J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1001. PubMed ID: 16214511
[TBL] [Abstract][Full Text] [Related]
18. Postinfarction heart failure: surgical and trans-coronary-venous transplantation of autologous myoblasts.
Siminiak T; Burchardt P; Kurpisz M
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S46-51. PubMed ID: 16501631
[TBL] [Abstract][Full Text] [Related]
19. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure.
Bonaros N; Rauf R; Wolf D; Margreiter E; Tzankov A; Schlechta B; Kocher A; Ott H; Schachner T; Hering S; Bonatti J; Laufer G
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1321-8. PubMed ID: 17140950
[TBL] [Abstract][Full Text] [Related]
20. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells.
Ott HC; Davis BH; Taylor DA
Semin Thorac Cardiovasc Surg; 2005; 17(4):348-60. PubMed ID: 16428043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
